Literature DB >> 6585216

Prostaglandins in human mammary cancer.

D M Watson, R W Kelly, R A Hawkins, W R Miller.   

Abstract

Prostaglandins E2 and F2 alpha (PGE2 and PGF2 alpha) were measured by Gas Liquid Chromatography-Mass Spectrometry (GLC-MS) in extracts of 100 human mammary carcinomas. All tumours contained measurable amounts of both prostaglandins but wide variations between individual tumours were observed. Values for PGE2 ranged from 7 to 762 ng g-1 tissue with a median of 100 ng g-1 tissue. Values for PGF2 alpha ranged from 3 to 475 ng g-1 tissue (median 60 ng g-1 tissue). There was a highly significant positive correlation between amounts of the 2 prostaglandins in individual tumours. Amounts of both PGE2 and PGF2 alpha were not significantly related to the menopausal status of the patients or the presence of oestrogen and progesterone receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6585216      PMCID: PMC1976779          DOI: 10.1038/bjc.1984.73

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Identification of arachidonate metabolites in normal, benign and malignant human mammary tissues.

Authors:  I F Stamford; M A Carroll; A Civier; C N Hensby; A Bennett
Journal:  J Pharm Pharmacol       Date:  1983-01       Impact factor: 3.765

3.  Mechanism for irreversible self-deactivation of prostaglandin synthetase.

Authors:  R W Egan; J Paxton; F A Kuehl
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

4.  A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues.

Authors:  R A Hawkins; A Hill; B Freedman
Journal:  Clin Chim Acta       Date:  1975-10-15       Impact factor: 3.786

5.  Determination of prostaglandins in body fluids and tissues.

Authors:  K Gréen
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1979

6.  Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

Authors:  P H Rolland; P M Martin; J Jacquemier; A M Rolland; M Toga
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

7.  Oestrogen receptor concentration in primary breast cancer and axillary node metastases.

Authors:  R A Hawkins; R Black; R J Steele; J M Dixon; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

8.  Unilateral breast-feeding and breast cancer.

Authors:  R Ing; N L Petrakis; J H Ho
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

  8 in total
  4 in total

1.  A study on the biological behavior of human brain tumors. Part I. Arachidonic acid metabolism and DNA content.

Authors:  P Gaetani; G Butti; C Chiabrando; M Danova; M G Castelli; A Riccardi; R Assietti; P Paoletti
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

2.  Prostaglandin F2 alpha in benign and malignant breast tumours.

Authors:  I B Vergote; G M Laekeman; G H Keersmaekers; F L Uyttenbroeck; J S Vanderheyden; G P Albertyn; C F Haensch; G J De Roy; A G Herman
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

3.  Prostaglandins and prognosis in human breast cancer.

Authors:  D M Watson; R W Kelly; W R Miller
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

4.  Breast cancer, prostaglandins and patient survival.

Authors:  A Bennett; I F Stamford; D A Berstock; F Dische; L Singh; R P A'Hern
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.